Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$53.98
-7.3%
$50.86
$17.36
$72.98
$12.19B2.2528.65 million shs31.66 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$24.81
-1.7%
$24.86
$20.92
$29.82
$140.89B0.5564.74 million shs64.53 million shs
Starbucks Corporation stock logo
SBUX
Starbucks
$78.46
-1.7%
$86.48
$75.50
$117.46
$89.19B1.019.58 million shs11.06 million shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
0.00%+2.60%+4.25%+12.67%+188.28%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%-9.36%-0.14%-3.29%-17.85%
Starbucks Corporation stock logo
SBUX
Starbucks
0.00%-9.21%-4.74%-17.36%-18.17%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$53.98
-7.3%
$50.86
$17.36
$72.98
$12.19B2.2528.65 million shs31.66 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$24.81
-1.7%
$24.86
$20.92
$29.82
$140.89B0.5564.74 million shs64.53 million shs
Starbucks Corporation stock logo
SBUX
Starbucks
$78.46
-1.7%
$86.48
$75.50
$117.46
$89.19B1.019.58 million shs11.06 million shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
0.00%+2.60%+4.25%+12.67%+188.28%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%-9.36%-0.14%-3.29%-17.85%
Starbucks Corporation stock logo
SBUX
Starbucks
0.00%-9.21%-4.74%-17.36%-18.17%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
1.93
Reduce$38.92-27.91% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.37
Hold$28.3514.30% Upside
Starbucks Corporation stock logo
SBUX
Starbucks
2.56
Moderate Buy$103.5631.99% Upside

Current Analyst Ratings Breakdown

Latest HIMS, SBUX, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/10/2025
Pfizer Inc. stock logo
PFE
Pfizer
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$33.00 ➝ $32.00
10/10/2025
Starbucks Corporation stock logo
SBUX
Starbucks
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetHold$88.00 ➝ $84.00
10/9/2025
Starbucks Corporation stock logo
SBUX
Starbucks
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutralMixed
10/8/2025
Pfizer Inc. stock logo
PFE
Pfizer
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
10/8/2025
Starbucks Corporation stock logo
SBUX
Starbucks
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
10/3/2025
Pfizer Inc. stock logo
PFE
Pfizer
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$28.00 ➝ $30.00
10/1/2025
Pfizer Inc. stock logo
PFE
Pfizer
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$28.00
10/1/2025
Starbucks Corporation stock logo
SBUX
Starbucks
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong SellHold
9/27/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
9/27/2025
Pfizer Inc. stock logo
PFE
Pfizer
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
9/27/2025
Starbucks Corporation stock logo
SBUX
Starbucks
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
(Data available from 10/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$1.48B8.26$0.35 per share153.20$2.16 per share24.99
Pfizer Inc. stock logo
PFE
Pfizer
$63.83B2.21$4.37 per share5.68$15.62 per share1.59
Starbucks Corporation stock logo
SBUX
Starbucks
$36.18B2.47$4.72 per share16.61($6.57) per share-11.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$126.04M$0.8067.48103.813.649.63%26.26%13.06%11/3/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.8813.198.190.8116.84%21.42%9.12%11/4/2025 (Estimated)
Starbucks Corporation stock logo
SBUX
Starbucks
$3.76B$2.3233.8221.443.877.18%-36.23%8.51%10/29/2025 (Estimated)

Latest HIMS, SBUX, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2025Q3 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.79N/AN/AN/A$16.94 billionN/A
11/3/2025Q3 2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.09N/AN/AN/A$578.99 millionN/A
10/29/2025Q4 2025
Starbucks Corporation stock logo
SBUX
Starbucks
$0.57N/AN/AN/A$9.41 billionN/A
8/5/2025Q2 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.58$0.78+$0.20$0.51$13.43 billion$14.65 billion
8/4/2025Q2 2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.18$0.17-$0.01$0.17$550.06 million$544.83 million
7/29/2025Q3 2025
Starbucks Corporation stock logo
SBUX
Starbucks
$0.64$0.50-$0.14$0.48$9.29 billion$9.46 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.93%N/A91.49%16 Years
Starbucks Corporation stock logo
SBUX
Starbucks
$2.443.11%N/A105.17%15 Years

Latest HIMS, SBUX, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/9/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.82%11/7/202511/7/202512/1/2025
9/8/2025
Starbucks Corporation stock logo
SBUX
Starbucks
quarterly$0.622.94%11/14/202511/14/202511/28/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
1.72
4.98
4.46
Pfizer Inc. stock logo
PFE
Pfizer
0.65
1.16
0.85
Starbucks Corporation stock logo
SBUX
Starbucks
N/A
0.76
0.55

Institutional Ownership

CompanyInstitutional Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Starbucks Corporation stock logo
SBUX
Starbucks
72.29%

Insider Ownership

CompanyInsider Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
13.71%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Starbucks Corporation stock logo
SBUX
Starbucks
0.09%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
1,637226.02 million195.03 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
81,0005.69 billion5.68 billionOptionable
Starbucks Corporation stock logo
SBUX
Starbucks
361,0001.14 billion1.14 billionOptionable

Recent News About These Companies

Better Buy: Dutch Bros vs. Starbucks
GFS Advisors LLC Takes Position in Starbucks Corporation $SBUX
Starbucks (NASDAQ:SBUX) Shares Unloaded Rep. Val T. Hoyle
Starbucks Earnings Preview: What to Expect
Starbucks Corporation $SBUX Shares Sold by US Bancorp DE

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$53.98 -4.27 (-7.33%)
Closing price 10/10/2025 03:59 PM Eastern
Extended Trading
$53.24 -0.74 (-1.37%)
As of 10/10/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Pfizer stock logo

Pfizer NYSE:PFE

$24.80 -0.44 (-1.72%)
Closing price 10/10/2025 03:59 PM Eastern
Extended Trading
$24.65 -0.15 (-0.62%)
As of 10/10/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Starbucks stock logo

Starbucks NASDAQ:SBUX

$78.46 -1.32 (-1.65%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$78.29 -0.17 (-0.22%)
As of 10/10/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks Coffee, Teavana, Seattle's Best Coffee, Ethos, Starbucks Reserve, and Princi brands. Starbucks Corporation was founded in 1971 and is based in Seattle, Washington.